Acelyrin Inc (NASDAQ:SLRN)’s traded shares stood at 5.55 million during the latest session, with the company’s beta value hitting 1.85. At the last check today, the stock’s price was $2.19, to imply an increase of 15.53% or $0.29 in intraday trading. The SLRN share’s 52-week high remains $8.89, putting it -305.94% down since that peak but still an impressive 15.07% since price per share fell to its 52-week low of $1.86. The company has a valuation of $220.22M, with an average of 1.0 million shares in intraday trading volume over the past 10 days and average of 1.05 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Acelyrin Inc (SLRN), translating to a mean rating of 1.50. Of 14 analyst(s) looking at the stock, 0 analyst(s) give SLRN a Sell rating. 0 of those analysts rate the stock as Overweight while 5 advise Hold as 9 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.74.
Acelyrin Inc (NASDAQ:SLRN) trade information
After registering a 15.53% upside in the latest session, Acelyrin Inc (SLRN) has traded red over the past five days. The 5-day price performance for the stock is 11.42%, and -0.23% over 30 days. With these gigs, the year-to-date price performance is -30.10%. Short interest in Acelyrin Inc (NASDAQ:SLRN) saw shorts transact 6.53 million shares and set a 4.09 days time to cover.
The extremes give us $6 and $15 for target low and target high price respectively. As such, SLRN has been trading -584.93% off suggested target high and -173.97% from its likely low.
Acelyrin Inc (SLRN) estimates and forecasts
Looking at statistics comparing Acelyrin Inc share performance against respective industry, we note that the company has outperformed competitors. Acelyrin Inc (SLRN) shares are -55.57% down over the last 6 months, with its year-to-date growth rate higher than industry average at 53.78% against 16.00%.
SLRN Dividends
Acelyrin Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Acelyrin Inc (NASDAQ:SLRN)’s Major holders
Acelyrin Inc insiders hold 8.85% of total outstanding shares, with institutional holders owning 99.44% of the shares at 109.10% float percentage. In total, 99.44% institutions holds shares in the company.
We also have Price (T.Rowe) Small-Cap Value Fund and Price (T.Rowe) Small Cap Stock Fund as the top two Mutual Funds with the largest holdings of the Acelyrin Inc (SLRN) shares. Going by data provided on Sep 30, 2024 , Price (T.Rowe) Small-Cap Value Fund holds roughly 2.84 shares. This is just over 2.83% of the total shares, with a market valuation of $6.2 million. Data from the same date shows that the other fund manager holds a little less at 2.59, or 2.58% of the shares, all valued at about 5.66 million.
